Skip to main content

Closed

RVMD: Revolution Medicines, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-70.0%

Financially safe

Stretched

Debt / equity0.29×

Interest coverage-39.0×

Current ratio6.80×

Revolution Medicines, Inc.

RVMDNASDAQ Global Select·USD·Closed

Revolution Medicines, Inc.

RVMDNASDAQ·USD·Closed

$187.53

−2.41%

$187.53

−$4.64 (2.41%)

52W Range

96thpctl

Volume

0.54×avg

Mkt Cap

39.87BUSD

P/E

-26.4TTM

Div Yield

–ann

52W Range

96thpctl

Volume

0.54×avg

Market Cap

39.87BUSD

P/E Ratio

-26.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings